Would you consider restarting IMID therapy in a patient with recent stroke while on IMID?

This is a very good question, and practice likely differs across institutions as data is limited. The discussion below refers primarily to the immunomodulatory (IMID) agents lenalidomide and pomalidomide.

As you are aware, IMID therapy is known to be associated with an increased risk for venous throm...